NOV 15, 2017 10:00 AM PST

WEBINAR: Characterization of immune checkpoint expression & infiltrating immune cells in TME by RNAscope ISH

Speaker

Abstract

DATE: November 15, 2017
TIME: 10:00AM PT

Interactions between tumor and immune cells in the tumor microenvironment (TME) play a key role in tumor progression and treatment response, with accumulating evidence indicating a crucial role for tumor infiltrating immune cells. Although infiltrating T cells have been correlated with improved clinical outcome, they are ineffective in eradicating tumors due to their inhibition by immune checkpoint molecules. 


Immune checkpoint inhibitors have demonstrated therapeutic efficacy and durable response for several tumor types, including NSCLC. However, the majority of patients are resistant or relapse after initial response. Characterizing the TME for checkpoint expression with single-cell and spatial resolution can provide critical insight into new immunotherapeutic strategies and identify new predictive biomarkers for stratifying patients most likely to benefit from immunotherapies. 


In addition, the visualization of immunosuppressive factors that contribute to tumor evasion by recruiting and modulating regulatory T cells and myeloid-derived cells could offer a more comprehensive understanding of the TME.
In this webinar, we will highlight the in situ visualization of the following targets at the single-cell level in the TME of NSCLC and ovarian cancer archived FFPE tissue samples using the highly specific and sensitive in situ hybridization assay RNAscope®: - Expression and co-expression profiles of therapeutic checkpoint targets including PD1, PD-L1, PD-L2, TIM3, LAG3, CTLA-4 and GITR in individual infiltrating immune cells within the morphological tissue context.
- Immune infiltration and state of lymphoid and myeloid cells in the TME by detecting key functional molecules, FOXP3, IFNg, CXCL10, and CCL22 combined with cell lineage markers CD4, CD8, CD68, and CD163.

 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
NOV 15, 2017 10:00 AM PST

WEBINAR: Characterization of immune checkpoint expression & infiltrating immune cells in TME by RNAscope ISH


Specialty

Cancer Research

Biomarkers

Immunology

Cancer Therapeutics

Cell Biology

Molecular Biology

Cancer Diagnostics

Oncology

Biotechnology

Molecular Diagnostics

Clinical Research

Cell Culture

Clinical Diagnostics

Immuno-Oncology

Genetics

Geography

North America59%

Europe27%

Asia8%

South America2%

Oceania1%

Africa1%

Registration Source

Website Visitors99%

WAVE Newsletter Promotion1%

Job Title

Scientist16%

Research Scientist15%

Executive14%

Student14%

Educator/Faculty10%

Post Doc8%

Medical Doctor/Specialist6%

Facility/Department Manager6%

Lab Management4%

Clinical Laboratory Scientist2%

Medical Laboratory Technician2%

Marketing/Sales2%

Biologist1%

Organization

Academic Institution10%

Research Institute9%

Biotech Company9%

Pharmaceutical Company5%

Hospital4%

Medical School4%

Life Science Company3%

Clinical Laboratory3%

Medical Center2%

Government2%

Non-Profit Organization2%

Consultant1%

Industrial Company1%

Contract Research Organization (Cro)1%

Other2%


Show Resources
Loading Comments...
Show Resources